PubMed=26607962; DOI=10.1038/srep17258; PMCID=PMC4660465
Canham M.A., Van Deusen A.L., Brison D.R., De Sousa P.A., Downie J.M., Devito L.G., Hewitt Z.A., Ilic D., Kimber S.J., Moore H.D., Murray H., Kunath T.
The molecular karyotype of 25 clinical-grade human embryonic stem cell lines.
Sci. Rep. 5:17258-17258(2015)

PubMed=27829140; DOI=10.1016/j.stemcr.2016.10.003; PMCID=PMC5106530
Baker D.E.C., Hirst A.J., Gokhale P.J., Juarez M.A., Williams S., Wheeler M., Bean K., Allison T.F., Moore H.D., Andrews P.W., Barbaric I.
Detecting genetic mosaicism in cultures of human pluripotent stem cells.
Stem Cell Reports 7:998-1012(2016)

PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative p53 mutations.
Nature 545:229-233(2017)